Neuropacs™ Corp.

Neuropacs™ Corp. is an AI-enabled imaging company focused on developing software tools to support the evaluation of neurodegenerative diseases. Automated Imaging Diagnostics LLC, is a wholly owned subsidiary of Neuropacs Corp. Its platform leverages advanced imaging analytics to provide insights for clinical and research applications. https://neuropacs.com/

https://neuropacs.com/ 1 press release

Press Releases from Neuropacs™ Corp.

Displaying 1 press releases

April 15, 2026

FDA Grants De Novo Classification to neuropacs™, a First-in-Class AI-Based MRI Diagnostic Aid for Parkinsonian Syndromes

Multicenter Clinical Evidence Supports Use of neuropacs™ to Assist Clinicians in Differentiating Parkinsonian Syndromes, Strengthening Commercial Momentum GAINESVILLE, Fla.-- Neuropacs™ Corp., an innovator in AI-enabled neurological imaging, today...

Read Full Release →

Neuropacs™ Corp.

Press Releases from Neuropacs™ Corp.

FDA Grants De Novo Classification to neuropacs™, a First-in-Class AI-Based MRI Diagnostic Aid for Parkinsonian Syndromes

🍪 We use cookies

Cookie Preferences

🔒 Necessary Cookies

📊 Analytics Cookies

🎯 Marketing Cookies